DYRK1A and pancreatic neoplasm: To demonstrate that DYRK1A may be exploited as a target for improved radiation therapy in pancreatic cancer, we used two separate sgRNAs to knock out the DYRK1A gene in TB32047 and MIA PaCa-2 cells and generated totally knocked out single clone cells (Figure 2A).